Market Exclusive

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Submission of Matters to a Vote of Security Holders

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Submission of Matters to a Vote of Security Holders

Item5.07

Submission of Matters to a Vote of Security
Holders

Zimmer Biomet Holdings, Inc. (the Company) held its annual
meeting of stockholders on May12, 2017. Stockholders took the
following actions:

elected eleven (11)directors for one-year terms ending at the
2018 annual meeting of stockholders (Proposal 1);
ratified the Audit Committees appointment of
PricewaterhouseCoopers LLP as the Companys independent
registered public accounting firm for 2017 (Proposal 2);
approved, on an advisory basis, the compensation of the
Companys named executive officers as disclosed in the
Companys proxy statement (Proposal 3); and
cast, on an advisory basis, a majority of votes in favor of a
frequency of one year for the holding of future advisory
votes on executive compensation (Proposal 4).

The vote tabulation for each proposal follows:

Proposal 1 Election of Directors

Nominee

For Against Abstained Broker Non- Votes

Christopher B. Begley

156,106,016 905,697 346,948 15,322,841

Betsy J. Bernard

156,292,247 905,661 160,753 15,322,841

Gail K. Boudreaux

155,625,654 1,580,778 152,229 15,322,841

David C. Dvorak

153,757,150 1,192,626 2,408,885 15,322,841

Michael J. Farrell

156,200,780 986,578 171,303 15,322,841

Larry C. Glasscock

154,286,017 2,899,521 173,123 15,322,841

Robert A. Hagemann

156,518,347 669,036 171,278 15,322,841

Arthur J. Higgins

147,175,383 10,012,694 170,584 15,322,841

Michael W. Michelson

156,383,688 802,655 172,318 15,322,841

Cecil B. Pickett,Ph.D.

156,303,879 886,058 168,724 15,322,841

Jeffrey K. Rhodes

156,399,560 785,001 174,100 15,322,841

Proposal 2 Ratification of the Appointment of the Independent
Registered Public Accounting Firm

For

Against

Abstained

Broker Non-Votes

170,775,072

1,741,672 164,758

Proposal 3 Advisory Vote to Approve Named Executive Officer
Compensation (Say on Pay)

For

Against

Abstained

Broker Non-Votes

144,554,233

11,306,266 1,498,162 15,322,841

Proposal 4 Advisory Vote on the Frequency of Future Say on Pay
Votes

One Year

Two Years

Three Years

Abstained

Broker Non-Votes

139,964,763

705,510 16,418,681 269,707 15,322,841

In accordance with the Board of Directors recommendation and the
voting results on this advisory proposal, the Board has
determined that the Company will hold future Say on Pay votes on
an annual basis until such time as the next advisory vote on
frequency is held.

About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental. ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Recent Trading Information
ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) closed its last trading session down -2.06 at 117.72 with 3,868,806 shares trading hands.

Exit mobile version